| 영문 | cystic fibrosis | 한글 | 낭성섬유증 |
|---|---|---|---|
| 설명 | 유전병의 하나로 땀샘, 기관지에서 점액을 분비하는 샘, 이자등의 외분비샘(몸 밖으로 액체를 분비하는 샘. 내분비샘을 제외한 모든 샘을 이른다)의 이상을 특징으로 하는 병이다. 중요한 병적인 변화는 주로 기관지에서 점액을 분비하는 분비샘에서 지나치게 점도가 높은 점액이 분비되어 기관지를 막아 호흡장애를 일으키는 폐의 병터이며, 땀에서 과도한 전해질 특히 염화나트륨(NaCl)이 분비되어 몸에 전해질이 부족하게 된다. 또 이자의 소화액을 분비하는 분비샘의 이상으로 이자관이 막히거나 이자의 기능이 떨어져서 소화의 장애를 일으키기도 한다. 유태계에 많으며 우리나라에는 아주 드물다. |
||
| 영문 | protein | 한글 | 단백질 |
|---|---|---|---|
| 설명 | 탄소, 수소, 산소, 질소, 황을 함유하고 있는 유기화합물로, 모든 세포의 원형질을 이루고 있는 기본 구성물질이다. 단백질은 그 단위인 아미노산들이 펩티드결합에 의해 결합되어 있으며, 보통 20개의 아미노산들이 다른 순서와 조성을 가지고 배열되어, 독특한 하나의 단백질을 형성하게 된다. |
||
| 영문 | fibrosis | 한글 | 섬유증, 섬유화 |
|---|---|---|---|
| 설명 | 아교질섬유를 형성하는 섬유조직의 증식으로 몸의 실질세포의 괴사나 손상에 이어서 나타나는 경우가 보통이다. 두 단계, 즉 손상부위에서 섬유모세포의 이주와 증식, 그리고 섬유모세포에 의한 세포의 바탕질 축적으로 진행된다. 피부의 경우 진피내 섬유모세포의 증식과 아교질 섬유의 증식이 있는 경우를 섬유화, 거의 아교질 섬유로만 구성되는 경우를 경화라고 한다. |
||
| CFTR | cystic fibrosis transmembrane conductance regulator |
|---|---|
| CFP | chronic false positive; Clinical Fellowship Program; cyclophosphamide, fluorouracil, prednisone; cys... |
| CFF | critical flicker fusion [test]; critical fusion frequency; cystic fibrosis factor; Cystic Fibrosis F... |
| TMP | thiamine monophosphate; thymidine monophosphate; thymidine-5'-monophosphate; thymolphthalein monopho... |
| MF | 1) Myelo-Fibrosis = Agnogenic Myeloid Metaplasia with Myelo-F... |
| CFTR | cystic fibrosis transmembrane conductance regulator protein |
|---|---|
| CFTR | Cystic Fibrosis Transmembrane Conductance Regulator |
| CFTR | Cystic Fibrosis Transmembrane Conductance Regulator Gene |
| CFTR | Cystic Fibrosis Transmembrane Regulator |
| CFP | Cystic fibrosis protein |
| cystic fibrosis transmembrane conductance regulator | Gene believed to be defective in cystic fibrosis. Gene encodes a chloride channel, homologous to a family of proteins that actively transport small solutes in an ATP dependent manner (ABC transporters). The regulator protein is a protein which is embedded in the cell membrane and acts as a channel for certain ions to be transported into or out of the cell. The disease cystic fibrosis is caused by a defect in the gene for this protein. (09 Oct 1997) |
|---|---|
| calcium dependent regulator protein | <protein> (CDRP) Early name for calmodulin. (18 Nov 1997) |
| cystic fibrosis | <chest medicine> A generalised disorder of infants, children and young adults, in which there is widespread dysfunction of the exocrine glands, characterised by signs of chronic pulmonary disease (due to excess mucus production in the respiratory tract), pancreatic deficiency, abnormally high levels of electrolytes in the sweat and occasionally by biliary cirrhosis. There is an ineffective immunologic defense against bacteria in the lungs. Pathologically, the pancreas shows obstruction of the pancreatic ducts by amorphous eosinophilic concretions, with consequent deficiency of pancreatic enzymes, resulting in steatorrhoea and azotorrhoea and intestinal malabsorption. The degree of involvement of organs and glandular systems may vary greatly, with consequent variations in the clinical picture. Inheritance: autosomal recessive. (13 Nov 1997) |
| cystic fibrosis antigen | Now known to be MRP 8. See: calgranulins. (18 Nov 1997) |
| transmembrane protein | <cell biology> A protein subunit in which the polypeptide chain is exposed on both sides of the membrane. The term does not apply when different subunits of protein complex are exposed at opposite surfaces. most integral membrane proteins are also transmembrane proteins. (13 Nov 1997) |
| genes, regulator | Genes which regulate or circumscribe the activity of other genes; specifically, genes which code for proteins (repressors or activators) which regulate the genetic transcription of the structural genes and/or regulatory genes. (12 Dec 1998) |
| regulator | A substance or process that regulates another substance or process. Growth regulators, substances that can alter the growth of a living organism. (05 Mar 2000) |
| regulator gene | A gene that produces a repressor substance that inhibits an operator gene when combined with it. It thus prevents production of a specific enzyme. When the enzyme is again in demand, a specific regulatory metabolite inhibits the repressor substance. (05 Mar 2000) |
| hepatoma transmembrane kinase | <enzyme> A transmembrane tyrosine kinase of the eph subfamily; genbank u07695 Registry number: EC 2.7.1.- Synonym: htk protein, htk gene product (26 Jun 1999) |
| transmembrane | Through or across a membrane. (05 Mar 2000) |
| transmembrane potential | <physiology> More correctly, transmembrane potential difference: the electrical potential difference across a plasma membrane. See: resting potential, action potential. (18 Nov 1997) |
| transmembrane transducer | A system that transmits a chemical or electrical signal across a membrane. Usually involves a transmembrane receptor protein that is thought to undergo a conformation change that is expressed on the inner surface of the membrane. Many such transducing species are dimeric and the conformation change may involve interaction between the two components. (18 Nov 1997) |
| African endomyocardial fibrosis | Fibrosis of the inner layers of the myocardium, often including the endocardium, causing diastolic restriction of the heart; indigenous to East Africa. (05 Mar 2000) |
| radiation fibrosis | The formation of scar tissue as a result of radiation therapy to the lung. (12 Dec 1998) |
| mediastinal fibrosis | <radiology> Histoplasmosis most common cause, can cause superior vena cava obstruction (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|